| Basics |
Oragenics Inc.
Oragenics Inc is a biopharmaceutical company which engages in the discovery, development and commercialization of technologies associated with oral health, broad spectrum antibiotics and other general health benefits.
|
| IPO Date: |
March 1, 2004 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$1.1M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.09 | 5.47%
|
| Avg Daily Range (30 D): |
$0.13 | 4.34%
|
| Avg Daily Range (90 D): |
$0.10 | 5.29%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.56M |
| Avg Daily Volume (30 D): |
.63M |
| Avg Daily Volume (90 D): |
3.03M |
| Trade Size |
| Avg Trade Size (Sh.): |
528 |
| Avg Trade Size (Sh.) (30 D): |
77 |
| Avg Trade Size (Sh.) (90 D): |
457 |
| Institutional Trades |
| Total Inst.Trades: |
14 |
| Avg Inst. Trade: |
$.83M |
| Avg Inst. Trade (30 D): |
$M |
| Avg Inst. Trade (90 D): |
$M |
| Avg Inst. Trade Volume: |
M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$.67M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
.38K |
|
|
| Financials |
| |
TTM |
FY 2025 |
Q3 2025 |
|
Basic EPS
|
$-.12
|
|
|
|
Diluted EPS
|
$-.12
|
|
|
|
Revenue
|
$ M
|
$
|
$
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -2.22M
|
$
|
$
|
|
Operating Income / Loss
|
$ -2.03M
|
$
|
$
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ M
|
$
|
$
|
|
PE Ratio
|
|
|
|
| Splits |
|
Jun 03, 2025:
1:30
|
|
Jan 23, 2023:
1:60
|
|
Jan 22, 2018:
1:10
|
|
Sep 28, 2010:
1:20
|
|
|
|
